Utilización de aprotinina como agente hemostático en la prótesis total de cadera
Aprotinin used as a hemostatic agent in THR
Leído
11317
Vecesse ha leído el artículo
1493
Total PDF
9824
Total HTML
Información del artículo
ISSN: 18884415Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 38 | 6 | 44 |
| 2025 11 | 91 | 30 | 121 |
| 2025 10 | 121 | 13 | 134 |
| 2025 9 | 139 | 18 | 157 |
| 2025 8 | 107 | 21 | 128 |
| 2025 7 | 108 | 21 | 129 |
| 2025 6 | 79 | 8 | 87 |
| 2025 5 | 140 | 10 | 150 |
| 2025 4 | 83 | 9 | 92 |
| 2025 3 | 100 | 10 | 110 |
| 2025 2 | 100 | 7 | 107 |
| 2025 1 | 94 | 8 | 102 |
| 2024 12 | 80 | 6 | 86 |
| 2024 11 | 81 | 11 | 92 |
| 2024 10 | 99 | 11 | 110 |
| 2024 9 | 154 | 10 | 164 |
| 2024 8 | 105 | 12 | 117 |
| 2024 7 | 75 | 11 | 86 |
| 2024 6 | 68 | 7 | 75 |
| 2024 5 | 76 | 7 | 83 |
| 2024 4 | 150 | 10 | 160 |
| 2024 3 | 103 | 11 | 114 |
| 2024 2 | 114 | 8 | 122 |
| 2024 1 | 152 | 13 | 165 |
| 2023 12 | 140 | 9 | 149 |
| 2023 11 | 250 | 20 | 270 |
| 2023 10 | 281 | 11 | 292 |
| 2023 9 | 139 | 7 | 146 |
| 2023 8 | 112 | 10 | 122 |
| 2023 7 | 185 | 12 | 197 |
| 2023 6 | 205 | 16 | 221 |
| 2023 5 | 260 | 14 | 274 |
| 2023 4 | 230 | 7 | 237 |
| 2023 3 | 324 | 7 | 331 |
| 2023 2 | 135 | 7 | 142 |
| 2022 1 | 84 | 4 | 88 |
| 2022 12 | 83 | 16 | 99 |
| 2022 11 | 109 | 19 | 128 |
| 2022 10 | 99 | 21 | 120 |
| 2022 9 | 61 | 23 | 84 |
| 2022 8 | 64 | 20 | 84 |
| 2022 7 | 69 | 12 | 81 |
| 2022 6 | 72 | 16 | 88 |
| 2022 5 | 95 | 22 | 117 |
| 2022 4 | 100 | 14 | 114 |
| 2022 3 | 123 | 15 | 138 |
| 2022 2 | 118 | 12 | 130 |
| 2021 1 | 88 | 12 | 100 |
| 2021 12 | 51 | 26 | 77 |
| 2021 11 | 68 | 20 | 88 |
| 2021 10 | 77 | 26 | 103 |
| 2021 9 | 70 | 15 | 85 |
| 2021 8 | 52 | 11 | 63 |
| 2021 7 | 28 | 17 | 45 |
| 2021 6 | 25 | 10 | 35 |
| 2021 5 | 20 | 8 | 28 |
| 2021 4 | 48 | 32 | 80 |
| 2021 3 | 25 | 18 | 43 |
| 2021 2 | 25 | 20 | 45 |
| 2020 1 | 8 | 8 | 16 |
| 2020 9 | 0 | 1 | 1 |
| 2020 8 | 0 | 2 | 2 |
| 2020 3 | 3 | 0 | 3 |
| 2020 2 | 1 | 2 | 3 |
| 2018 2 | 9 | 0 | 9 |
| 2018 1 | 14 | 0 | 14 |
| 2017 12 | 16 | 4 | 20 |
| 2017 11 | 15 | 3 | 18 |
| 2017 10 | 26 | 2 | 28 |
| 2017 9 | 15 | 13 | 28 |
| 2017 8 | 12 | 28 | 40 |
| 2017 7 | 16 | 24 | 40 |
| 2017 6 | 16 | 12 | 28 |
| 2017 5 | 22 | 8 | 30 |
| 2017 4 | 13 | 75 | 88 |
| 2017 3 | 19 | 13 | 32 |
| 2017 2 | 46 | 2 | 48 |
| 2016 1 | 17 | 0 | 17 |
| 2016 12 | 33 | 4 | 37 |
| 2016 11 | 40 | 9 | 49 |
| 2016 10 | 44 | 6 | 50 |
| 2016 9 | 56 | 1 | 57 |
| 2016 8 | 19 | 3 | 22 |
| 2016 7 | 36 | 2 | 38 |
| 2016 6 | 46 | 16 | 62 |
| 2016 5 | 34 | 14 | 48 |
| 2016 4 | 68 | 18 | 86 |
| 2016 3 | 60 | 20 | 80 |
| 2016 2 | 42 | 48 | 90 |
| 2015 1 | 32 | 38 | 70 |
| 2015 12 | 28 | 30 | 58 |
| 2015 11 | 54 | 20 | 74 |
| 2015 10 | 54 | 34 | 88 |
| 2015 9 | 38 | 18 | 56 |
| 2015 8 | 76 | 4 | 80 |
| 2015 7 | 68 | 10 | 78 |
| 2015 6 | 30 | 12 | 42 |
| 2015 5 | 42 | 10 | 52 |
| 2015 4 | 52 | 30 | 82 |
| 2015 3 | 52 | 4 | 56 |
| 2015 2 | 46 | 20 | 66 |
| 2015 1 | 62 | 6 | 68 |
| 2014 12 | 94 | 8 | 102 |
| 2014 11 | 64 | 2 | 66 |
| 2014 10 | 88 | 14 | 102 |
| 2014 9 | 78 | 6 | 84 |
| 2014 8 | 70 | 10 | 80 |
| 2014 7 | 74 | 4 | 78 |
| 2014 6 | 80 | 4 | 84 |
| 2014 5 | 62 | 6 | 68 |
| 2014 4 | 54 | 6 | 60 |
| 2014 3 | 36 | 4 | 40 |
| 2014 2 | 26 | 4 | 30 |
| 2014 1 | 26 | 4 | 30 |
| 2013 12 | 26 | 6 | 32 |
| 2013 11 | 30 | 16 | 46 |
| 2013 10 | 48 | 8 | 56 |
| 2013 9 | 26 | 4 | 30 |
| 2013 8 | 30 | 2 | 32 |
| 2013 7 | 22 | 2 | 24 |
| 2013 6 | 4 | 0 | 4 |
| 2013 5 | 2 | 2 | 4 |
| 2006 6 | 1132 | 0 | 1132 |
Mostrar todo
